{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T16:07:13Z","timestamp":1779466033940,"version":"3.53.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,22]]},"DOI":"10.7759\/cureus.109435","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:39:47Z","timestamp":1779464387000},"source":"Crossref","is-referenced-by-count":0,"title":["Synchronous Lobular Breast Cancer and Lung Adenocarcinoma: \u0391 Case Report"],"prefix":"10.7759","author":[{"given":"Varvara","family":"Pantelidou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evangelos","family":"Perdikakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Eleftheriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savvas","family":"Lampridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Tsantila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Permekerlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5011-4","article-title":"Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: a case report","volume":"18","author":"Jin B","year":"2018","unstructured":"Jin B, Zhang S, Chuang X, et al.. Breast cancer and synchronous multiple primary lung adenocarcinomas with heterogeneous mutations: a case report. BMC Cancer. 2018, 18:1138. 10.1186\/s12885-018-5011-4","journal-title":"BMC Cancer"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/00008469-200508000-00002","article-title":"International rules for multiple primary cancers (ICD-0 third edition)","volume":"14","year":"2005","unstructured":"International rules for multiple primary cancers (ICD-0 third edition). Eur J Cancer Prev. 2005, 14.307-8. 10.1097\/00008469-200508000-00002","journal-title":"Eur J Cancer Prev"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-024-02897-y","article-title":"Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report","volume":"24","author":"Gan J","year":"2024","unstructured":"Gan J, Liu M, Liu F, Wen J, Fu W, Jia J. Synchronous double primary small cell lung cancer and invasive ductal breast carcinoma: a case report. BMC Pulm Med. 2024, 24:93. 10.1186\/s12890-024-02897-y","journal-title":"BMC Pulm Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.21037\/acr-23-194","article-title":"A case report of synchronous breast and lung cancer with three different pathologic diagnoses","volume":"8","author":"Khan N","year":"2024","unstructured":"Khan N, de la Torre M, Moghaddas H, Fromer N, Melnikau S. A case report of synchronous breast and lung cancer with three different pathologic diagnoses. AME Case Rep. 2024, 8:68. 10.21037\/acr-23-194","journal-title":"AME Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.86620","article-title":"Synchronous primary lung cancer: an unusual triple presentation","volume":"17","author":"Fernandes D","year":"2025","unstructured":"Fernandes D, Ip J, Filipe J, Barata R, Winckler P. Synchronous primary lung cancer: an unusual triple presentation. Cureus. 2025, 17:e86620. 10.7759\/cureus.86620","journal-title":"Cureus"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/jcrt.jcrt_2321_22","article-title":"Clinicopathological analysis of patients with dual malignancies: a retrospective study","volume":"20","author":"Thakur N","year":"2024","unstructured":"Thakur N, Kaur H, Sudan M, Jain N. Clinicopathological analysis of patients with dual malignancies: a retrospective study. J Cancer Res Ther. 2024, 20:822-6. 10.4103\/jcrt.jcrt_2321_22","journal-title":"J Cancer Res Ther"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2019-232421","article-title":"Synchronous metaplastic breast carcinoma and lung adenocarcinoma: a rare case and review of the literature","volume":"13","author":"Lane R","year":"2020","unstructured":"Lane R, Yan F, Higgins D, Agarwal G. Synchronous metaplastic breast carcinoma and lung adenocarcinoma: a rare case and review of the literature. BMJ Case Rep. 2020, 13:10.1136\/bcr-2019-232421","journal-title":"BMJ Case Rep"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2022.13604","article-title":"Analysis of primary synchronous breast invasive ductal carcinoma and lung adenocarcinoma with next-generation sequencing: a case report","volume":"25","author":"Wu D","year":"2023","unstructured":"Wu D, Yu J, Guo L, Wei X, Tian Z, Duan X. Analysis of primary synchronous breast invasive ductal carcinoma and lung adenocarcinoma with next-generation sequencing: a case report. Oncol Lett. 2023, 25:18. 10.3892\/ol.2022.13604","journal-title":"Oncol Lett"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s00428-024-03926-1","article-title":"TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities","volume":"485","author":"M\u00f6ller K","year":"2024","unstructured":"M\u00f6ller K, Gulzar T, Lennartz M, et al.. TTF-1 is a highly sensitive but not fully specific marker for pulmonary and thyroidal cancer: a tissue microarray study evaluating more than 17,000 tumors from 152 different tumor entities. Virchows Arch. 2024, 485:815-28. 10.1007\/s00428-024-03926-1","journal-title":"Virchows Arch"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10549-024-07361-3","article-title":"The contribution of second primary cancers to the mortality of patients with a first primary breast cancer","volume":"207","author":"Gon\u00e7alves E","year":"2024","unstructured":"Gon\u00e7alves E, Fontes F, Rodrigues JR, Calisto R, Bento MJ, Lunet N, Morais S. The contribution of second primary cancers to the mortality of patients with a first primary breast cancer. Breast Cancer Res Treat. 2024, 207:323-30. 10.1007\/s10549-024-07361-3","journal-title":"Breast Cancer Res Treat"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.7296","article-title":"Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer","volume":"13","author":"Hao Y","year":"2024","unstructured":"Hao Y, Zhang X, Cui G, Qi X, Jiang Z, Yu L. Clinicopathological features, prognostic factor analysis, and survival nomogram of patients with double primary cancers involving lung cancer. Cancer Med. 2024, 13:e7296. 10.1002\/cam4.7296","journal-title":"Cancer Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2025.103001","article-title":"Invasive lobular carcinoma: strategies and perspectives from the lobular breast cancer research group","volume":"140","author":"Corso G","year":"2025","unstructured":"Corso G, Shen S, Criscitiello C, et al.. Invasive lobular carcinoma: strategies and perspectives from the lobular breast cancer research group. Cancer Treat Rev. 2025, 140:103001. 10.1016\/j.ctrv.2025.103001","journal-title":"Cancer Treat Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/onco.13734","article-title":"Comprehensive review of molecular mechanisms and clinical features of invasive lobular cancer","volume":"26","author":"Pramod N","year":"2021","unstructured":"Pramod N, Nigam A, Basree M, et al.. Comprehensive review of molecular mechanisms and clinical features of invasive lobular cancer. Oncologist. 2021, 26:e943-53. 10.1002\/onco.13734","journal-title":"Oncologist"},{"key":"ref14","unstructured":"National Comprehensive Cancer Network. NCCN guidelines. \u039d\u03bfn-small cell lung cancer. (2026). Accessed. April 7, 2026: https:\/\/www.nccn.org\/guidelines\/guidelines-detail."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/493675-synchronous-lobular-breast-cancer-and-lung-adenocarcinoma--case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T15:39:48Z","timestamp":1779464388000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/493675-synchronous-lobular-breast-cancer-and-lung-adenocarcinoma--case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":14,"URL":"https:\/\/doi.org\/10.7759\/cureus.109435","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}